A carregar...
Longitudinal MRI in progressive supranuclear palsy: a new combined score for clinical trials
BACKGROUND: Two recent randomized, placebo-controlled phase II/III trials (clinicaltrials.gov: NCT01110720, NCT01049399) of davunetide and tideglusib in progressive supranuclear palsy (PSP) generated prospective, 1-year longitudinal datasets of high-resolution T1-weighted 3D MRI. OBJECTIVES: Develop...
Na minha lista:
| Publicado no: | Mov Disord |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5808453/ https://ncbi.nlm.nih.gov/pubmed/28436538 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.26973 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|